Literature DB >> 19854606

Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.

Y P Liu1, L Ma, S J Wang, Y N Chen, G X Wu, M Han, X L Wang.   

Abstract

AIMS: Although the positive lymph node (LN) metastasis in patients with thoracic esophageal squamous cell carcinoma carcinoma (SCC) has been reported to be a risk factor to reduce long-term survival, only a few studies have so far evaluated the lymph node metastasis among this group of patients. The purpose of this study was to evaluate the impact of lymph node positivity and ratio on survival of esophageal SCC.
METHODS: All patients undergoing esophagectomy at the Forth Hospital of Hebei Medical University between January 1986 and December 2002 were reviewed. Survival curves were estimated using the Kaplan-Meier method.
RESULTS: Of 1,325 patients with invasive cancer, had squamous cell cancer of the esophagus. Median overall survival (OS) of the entire group was 36.7 months and 5-year OS was 39.3%. The most significant prognostic factor for overall survival was the presence of positive LN (P<0.01). Additionally, patients with zero involved LN had a 5-year survival of 49.1%, while patients with 1-3 positive LN and >3 positive LN had 5-year survival of 19.5% and 11.0%, respectively (P<0.01). Finally, an increasing ratio of positive to examined LN was linearly associated with a worsening 5-year survival, patients with <25%, 25%-50% and >50% positive LN had 5-year survival of 47.53%, 14.6% and 8.9%, respectively (P<0.01).
CONCLUSION: Increasing number of positive LN in patients with esophageal cancer and increasing ratio of metastatic to examine LN portend a poor prognosis. These factors should play an important role in predicting prognosis of patients. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19854606     DOI: 10.1016/j.ejso.2009.09.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  41 in total

1.  Recurrence risk model for esophageal cancer after radical surgery.

Authors:  Jincheng Lu; Hua Tao; Dan Song; Cheng Chen
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

2.  Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Authors:  Chen Wei; Wen-Ying Deng; Ning Li; Wei Shen; Chi Zhang; Jia-Yu Liu; Su-Xia Luo
Journal:  Dig Dis Sci       Date:  2015-05-05       Impact factor: 3.199

Review 3.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

4.  Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Authors:  Jian-Wei Zhang; Yun-Mian Chu; Zhong-Min Lan; Xiao-Long Tang; Ying-Tai Chen; Cheng-Feng Wang; Xu Che
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Authors:  Huan Wang; Xiao-Ming Xing; Lei-Na Ma; Lian Liu; Jing Hao; Ling-Xin Feng; Zhuang Yu
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

6.  Prognostic significance of lymph node characteristics on survival in esophageal squamous cell carcinomas.

Authors:  Ning Wu; Zhiming Chen; Liewen Pang; Qinyun Ma; Gang Chen
Journal:  Wien Klin Wochenschr       Date:  2013-01-05       Impact factor: 1.704

7.  Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer.

Authors:  Nicole D Fleming; Michael Frumovitz; Kathleen M Schmeler; Ricardo dos Reis; Mark F Munsell; Patricia J Eifel; Pamela T Soliman; Alpa M Nick; Shannon N Westin; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2014-11-18       Impact factor: 5.482

8.  Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.

Authors:  Sumanta Dutta; Andrew B C Crumley; Grant M Fullarton; Paul G Horgan; Donald C McMillan
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

9.  Correlation between MTA2 overexpression and tumour progression in esophageal squamous cell carcinoma.

Authors:  Y P Liu; B E Shan; X L Wang; L Ma
Journal:  Exp Ther Med       Date:  2012-02-07       Impact factor: 2.447

10.  Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.

Authors:  Nicole D Fleming; Pamela T Soliman; Shannon N Westin; Ricardo dos Reis; Mark Munsell; Ann H Klopp; Michael Frumovitz; Alpa M Nick; Kathleen Schmeler; Pedro T Ramirez
Journal:  Int J Gynecol Cancer       Date:  2015-10       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.